Clinical Trial Update: Exploratory Study of Changes in Disease Activity and Biomarkers With ABR-215757 in Patients With Mild Active Systemic Lupus Erythematosus (SLE) [Phase 2]

View source ↗

Summary

This is a Phase 2 exploratory study of ABR-215757 in patients with mild active systemic lupus erythematosus, designed to assess changes in disease activity and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• ABR-215757

Snippet

Sponsor: Active Biotech AB | Conditions: Systemic Lupus Erythematosus | Phase 2 | Status: COMPLETED